Retrospective analysis of clinical characteristics and treatment of patients with immune checkpoint inhibitors-induced adrenal insufficiency
The median time to AI onset and ICIs cycles administered are key indicators of AI development. Both IAD and hypophysitis are common secondary AI manifestations; glucocorticoid replacement enables safe ICIs continuation.
Authors
- L. Zhang (ORCID: https://orcid.org/0000-0003-2153-4856)
- Chuantao Zhang (ORCID: https://orcid.org/0000-0003-1212-971X)
- Zhongjun Shao (ORCID: https://orcid.org/0000-0002-3236-3629)
- Man Jiang (ORCID: https://orcid.org/0000-0002-0803-8113)
- Ning Liu (ORCID: https://orcid.org/0009-0008-5231-1835)
- Huiyun Wang
- Xiao‐Chun Huang (ORCID: https://orcid.org/0009-0003-8168-9013)
- Shanai Song
- Helei Hou
Institutions
- Qingdao University (CN)
- Qingdao Agricultural University (CN)
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-08-18
- DOI
- https://doi.org/10.3389/fonc.2025.1614223
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shandong Province